Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 21 November 2025

Sec. Drugs Outcomes Research and Policies

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1743351

Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology

Merc Cases
Mercè Cases1*Rachel Giles
Rachel Giles2*Tams ghTamás Ágh3Maria PigginMaria Piggin4Jan Geissler,Jan Geissler1,5Monica RacovitaMonica Racovita6Judit HagymsyJudit Hagymásy3Lora Ruth WoguLora Ruth Wogu7kos JzwiakÁkos Józwiak3Albina Hyseni-BocolliAlbina Hyseni-Bocolli8Dalma Hosszú,&#x;Dalma Hosszú3,9Ananda Plate,&#x;Ananda Plate1,2 EuroACT Working Group EuroACT Working Group
  • 1European Patient Advocacy Institute, Riemerling, Germany
  • 2VHL Europa, Vlaardingen, Netherlands
  • 3Syreon Research Institute, Budapest, Hungary
  • 4PNH Global Alliance, Tiel, Netherlands
  • 5Workgroup of European Cancer Patient Advocacy Networks, Barcelona, Spain
  • 6Myeloma Patients Europe, Brussels, Belgium
  • 7European Sickle Cell Federation-ESCF, Dublin, Ireland
  • 8Childhood Cancer International – Europe, Vienna, Austria
  • 9University of Pécs Institute of Psychology, Pécs, Hungary

A Correction on
Methodological study protocol for the European Atlas of clinical trials in cancer and haematology

by Cases M, Giles R, Ágh T, Piggin M, Geissler J, Racovita M, Hagymásy J, Ruth Wogu L, Józwiak Á, Hyseni-Bocolli A, Hosszú D, Plate A and EuroACT Working Group (2025). Front. Pharmacol. 16:1558556. doi: 10.3389/fphar.2025.1558556

Authors Judit Hagymásy, Ákos Józwiak and Dalma Hosszú were erroneously assigned to affiliation 4 PNH Global Alliance, Tiel, Netherlands. This affiliation has now been removed for author Judit Hagymásy, Ákos Józwiak and Dalma Hosszú.

Affiliation 3 Syreon Research Institute, Budapest, Hungary was omitted for authors Judit Hagymásy, Ákos Józwiak and Dalma Hosszú. This affiliation has now been added for authors Judit Hagymásy, Ákos Józwiak and Dalma Hosszú.

The collaborative group EuroACT Working Group was erroneously not credited with authorship in the published article. The consortium should be credited with authorship.

The list of members of the EuroACT Working Group was omitted from the published article. The section Group Members of the EuroACT Working Group has been added to the article as follows: Attila Imre, Anna Bögös, Natacha Bolaños, Susanna Leto di Priolo, Kate Morgan.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer, haematology, rare disease, patient, patient reported outcome, clinical trials

Citation: Cases M, Giles R, Ágh T, Piggin M, Geissler J, Racovita M, Hagymásy J, Ruth Wogu L, Józwiak Á, Hyseni-Bocolli A, Hosszú D, Plate A and EuroACT Working Group (2025) Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology. Front. Pharmacol. 16:1743351. doi: 10.3389/fphar.2025.1743351

Received: 10 November 2025; Accepted: 11 November 2025;
Published: 21 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Cases, Giles, Ágh, Piggin, Geissler, Racovita, Hagymásy, Ruth Wogu, Józwiak, Hyseni-Bocolli, Hosszú, Plate and EuroACT Working Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mercè Cases, bWVyY2UuY2FzZXNAcGF0aWVudGFkdm9jYWN5LmV1; Rachel Giles, cmFjaGVsaGVsZW5naWxlc0BnbWFpbC5jb20=

These authors have contributed equally to this work and share last authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.